Our results demonstrated moderate evidence of a decrease in the population of CD14++CD16− Classical monocytes and moderate evidence of an increase in both Intermediate (CD14++CD16+) and Non-classical (CD14+CD16++) monocytes in PD compared to HC subjects (Fig. 1b). Here, CD14 is linked to Parkinson disease.